R.A. Session II - Insider Trading & Ownership

Entity
Individual
Location
C/O Avexis, Inc., 2275 Half Day Road, Suite 200, Bannockburn, IL
Summary
The estimated net worth of R.A. Session II is at least $14.7M dollars as of July 14, 2023. R.A. Session II is the 10%+ Owner of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $14.7M.
All Insider Reports
All Insider Reports

Ownership of R.A. Session II

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TSHA Taysha Gene Therapies, Inc. 10%+ Owner $14.7M Jul 12, 2023

Insider Transactions Reported by R.A. Session II:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.